INT241876

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.10
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 0.54
Pain Relevance 0.06

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

mitochondrion (SARDH) oxidoreductase activity (SARDH) biological_process (SARDH)
cytoplasm (SARDH)
SARDH (Homo sapiens)
Pain Link Frequency Relevance Heat
Bioavailability 6 74.64 Quite High
corticosteroid 58 55.28 Quite High
headache 4 43.28 Quite Low
Inflammation 14 5.00 Very Low Very Low Very Low
Antihistamine 6 5.00 Very Low Very Low Very Low
cytokine 2 5.00 Very Low Very Low Very Low
depression 2 5.00 Very Low Very Low Very Low
Bile 2 5.00 Very Low Very Low Very Low
tolerance 2 5.00 Very Low Very Low Very Low
cva 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Rhinitis 98 92.60 High High
Sneezing 8 63.28 Quite High
Headache 4 43.28 Quite Low
Fatigue 4 42.00 Quite Low
Pruritus 8 25.04 Quite Low
Asthma 30 5.00 Very Low Very Low Very Low
INFLAMMATION 14 5.00 Very Low Very Low Very Low
Osteoporosis 8 5.00 Very Low Very Low Very Low
Frailty 6 5.00 Very Low Very Low Very Low
Hypersensitivity 6 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
g/day) administration was generally safe and well tolerated in both healthy volunteers and asymptomatic subjects with SAR.
SAR Binding (tolerated) of
1) Confidence 0.10 Published 2008 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2504079 Disease Relevance 0.16 Pain Relevance 0.06
g/day dose of ciclesonide is the most effective dose studied for the amelioration of symptoms associated with SAR (Ratner et al 2006a).


SAR Binding (associated) of
2) Confidence 0.09 Published 2008 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2504079 Disease Relevance 0.38 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox